Correlation Between FWBI Old and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both FWBI Old and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FWBI Old and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FWBI Old and Salarius Pharmaceuticals, you can compare the effects of market volatilities on FWBI Old and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FWBI Old with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of FWBI Old and Salarius Pharmaceuticals.
Diversification Opportunities for FWBI Old and Salarius Pharmaceuticals
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between FWBI and Salarius is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding FWBI Old and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and FWBI Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FWBI Old are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of FWBI Old i.e., FWBI Old and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between FWBI Old and Salarius Pharmaceuticals
If you would invest 174.00 in Salarius Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 41.00 from holding Salarius Pharmaceuticals or generate 23.56% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 5.26% |
Values | Daily Returns |
FWBI Old vs. Salarius Pharmaceuticals
Performance |
Timeline |
FWBI Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Salarius Pharmaceuticals |
FWBI Old and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with FWBI Old and Salarius Pharmaceuticals
The main advantage of trading using opposite FWBI Old and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FWBI Old position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.FWBI Old vs. Quoin Pharmaceuticals Ltd | FWBI Old vs. Revelation Biosciences | FWBI Old vs. Dermata Therapeutics | FWBI Old vs. LMF Acquisition Opportunities |
Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Histogen | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |